0001209191-20-044360.txt : 20200731
0001209191-20-044360.hdr.sgml : 20200731
20200731210518
ACCESSION NUMBER: 0001209191-20-044360
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200107
FILED AS OF DATE: 20200731
DATE AS OF CHANGE: 20200731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BREITMEYER JAMES B
CENTRAL INDEX KEY: 0001244823
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 201067596
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2020-01-07
2020-01-09
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001244823
BREITMEYER JAMES B
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Stock Option
22000.00
2020-01-07
4
A
0
22000
0.00
A
2030-01-07
Common Stock
22000
22000
I
By Spouse
The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
The options generally vest as follows: 25% of the total number of shares subject to the options shall vest on the first anniversary of the vesting commencement date and 1/48th of the total number of shares subject to the options shall vest on each monthly anniversary of the vesting commencement date thereafter, subject to the option recipient's continuous service to the Corporation on each such vesting date, so that the options shall be fully vested on the forth anniversary of the vesting commencement date.
22,000 Stock Options granted to Mary Breitmeyer with a January 7,2020 transaction date .
/s/ Hazel M. Aker, Attorney-in-fact
2020-07-31